Lipid and Polymeric Nanoparticles: Successful Strategies for Nose-to-Brain Drug Delivery in the Treatment of Depression and Anxiety Disorders
Intranasal administration has gained an increasing interest for brain drug delivery since it allows direct transport through neuronal pathways, which can be quite advantageous for central nervous system disorders, such as depression and anxiety. Nanoparticles have been studied as possible alternativ...
Main Authors: | Margarida Alberto, Ana Cláudia Paiva-Santos, Francisco Veiga, Patrícia C. Pires |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/14/12/2742 |
Similar Items
-
Intranasal Nanoparticles for the Treatment of Depression and Anxiety Disorders
by: Margarida Alberto, et al.
Published: (2022-12-01) -
Epilepsy Disease and Nose-to-Brain Delivery of Polymeric Nanoparticles: An Overview
by: Teresa Musumeci, et al.
Published: (2019-03-01) -
Self-Assembled Lecithin-Chitosan Nanoparticles Improved Rotigotine Nose-to-Brain Delivery and Brain Targeting Efficiency
by: Paramita Saha, et al.
Published: (2023-03-01) -
Intranasal delivery of nanostructured lipid carriers, solid lipid nanoparticles and nanoemulsions: A current overview of in vivo studies
by: Cláudia Pina Costa, et al.
Published: (2021-04-01) -
Solid lipid nanoparticles for nose to brain delivery of haloperidol: in vitro drug release and pharmacokinetics evaluation
by: Mohd Yasir, et al.
Published: (2014-12-01)